HeartSciences Supplements Merger Proxy After Seven Shareholder Demand Letters
HeartSciences added disclosures to its merger proxy, including Fortitude valuation details, after receiving seven shareholder demand letters.
HeartSciences added disclosures to its merger proxy, including Fortitude valuation details, after receiving seven shareholder demand letters.